Back to search results

Acceptance and Commitment Therapy for Hepatobiliary Cancers

This study is testing a type of behavioral therapy called Acceptance and Commitment Therapy for Hepatobiliary Cancers (ACT-HBC) to see if it can help reduce distress in people with hepatobiliary cancer (HBC). Patients with HBC often experience significant emotional distress. ACT-HBC is designed to help you cope with difficult thoughts and feelings and stay connected to what's important in your life. The study aims to enroll 60 participants who are at least 18 years old, can speak and read English, and live in Iowa, Minnesota, or Wisconsin. Researchers will measure how satisfied participants are and how often they attend the therapy sessions over 8 weeks to see if ACT-HBC is helpful.

Study design
This is an interventional study planning to enroll 60 participants. It is not specified if it is randomized or blinded.
What's involved
You would attend telehealth group sessions for Acceptance and Commitment Therapy for Hepatobiliary Cancers (ACT-HBC) and complete questionnaires. These activities would occur over 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints, patient satisfaction and session attendance, are measured at 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07124546

Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial

Recruiting
NAAges 18+InterventionalSupportive care
Mayo Clinic
~60 participants
Updated 2026-08-04 on ClinicalTrials.gov
What's tested:Acceptance and Commitment TherapyQuestionnaire AdministrationTelemedicine

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient satisfaction
Measured over At 8 weeks
+1 more outcome measured

Conditions

Malignant Hepatobiliary Neoplasm

Explore related trials

Hepatobiliary Cancer

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Carrie A Bronars, PhD, LP · PRINCIPAL_INVESTIGATOR · Mayo Clinic in Rochester

Who to contact

Sofia Hammel
[email protected]
507-255-0760
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Incurable HBC and breast cancer diagnosis
Age \>= 18 years
Able to provide written informed consent
Verbally endorse cancer distress
Access to the internet
Read and write in English
Reside in the states of Minnesota

Exclusion

Other psychological therapy that started =\< 2 months prior to prospective enrollment
Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion
Cancer remission

What this trial measures

  • Patient satisfactionAt 8 weeks

    The Institute for Healthcare Improvement 10-point Likert scale (0-10) asks: "Would you recommend this program to your friends and family?" A score ≥ 7 indicates high individual satisfaction. Program satisfaction is achieved if 50% of individuals meet this cut-off.

  • Patient session attendance (Feasibility)At 8 weeks

    Feasibility will be determined by the number of patients attending ≥ 4 sessions.